BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16324834)

  • 1. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
    Song SY; Son HJ; Nam E; Rhee JC; Park C
    Eur J Cancer; 2006 Jan; 42(1):101-8. PubMed ID: 16324834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
    Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
    Takenaka K; Ishikawa S; Kawano Y; Yanagihara K; Miyahara R; Otake Y; Morioka Y; Takahashi C; Noda M; Wada H; Tanaka F
    Eur J Cancer; 2004 Jul; 40(10):1617-23. PubMed ID: 15196549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
    Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
    Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
    Furumoto K; Arii S; Mori A; Furuyama H; Gorrin Rivas MJ; Nakao T; Isobe N; Murata T; Takahashi C; Noda M; Imamura M
    Hepatology; 2001 Jan; 33(1):189-95. PubMed ID: 11124835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
    Clark JC; Thomas DM; Choong PF; Dass CR
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
    Chang HC; Cho CY; Hung WC
    Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
    Takagi S; Hoshino Y; Osaki T; Okumura M; Fuginaga T
    Exp Oncol; 2007 Mar; 29(1):30-4. PubMed ID: 17431385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro.
    Tian QS; Li DC
    Saudi Med J; 2010 Jul; 31(7):752-8. PubMed ID: 20635007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of MT1-MMP and RECK protein in human gastric carcinoma].
    Shen B; Zheng MQ; Xu XY; Mo FG; Zhang T; Feng JF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):364-7. PubMed ID: 22338226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
    van der Jagt MF; Sweep FC; Waas ET; Hendriks T; Ruers TJ; Merry AH; Wobbes T; Span PN
    Cancer Lett; 2006 Jun; 237(2):289-97. PubMed ID: 16046057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis.
    Miki T; Shamma A; Kitajima S; Takegami Y; Noda M; Nakashima Y; Watanabe K; Takahashi C
    Mol Cancer Res; 2010 May; 8(5):665-76. PubMed ID: 20407016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG.
    Manikandan P; Murugan RS; Priyadarsini RV; Vinothini G; Nagini S
    Life Sci; 2010 Jun; 86(25-26):936-41. PubMed ID: 20434464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.